VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this
morning announced that it has engaged with Linneo Health S.L., a subsidiary of
Alcaliber S.A., to be its European medical cannabis supply partner. A European
leader in the pharmaceutical cannabis industry, Linneo Health recently received
its EU-GMP (“Good Manufacturing Practices”) certification from the Spanish
regulatory authorities. According to the update, the multi-year agreement
includes increasing supply volumes as VIVO expands in the European medical
market. “Our partnership with Linneo Health is part of our strategic priority
to accelerate international market growth,” VIVO CEO Barry Fishman said in the
news release. “We are excited to have an EU-GMP certified source of medical
cannabis located within Europe. Through this partnership, we expect to be able
to supply the European high-growth market with premium medical cannabis
products and services. Our European based supply will allow VIVO to contribute
to addressing the unmet medical needs of patients in Germany, which is one of
our key target markets for international expansion.”
To view the full press release, visit http://ibn.fm/X9J8Z
About VIVO Cannabis(TM)
VIVO, based in Napanee, Ontario, is recognized for trusted,
high-quality products and services. It holds production and sales licenses from
Health Canada and operates world-class indoor cultivation facilities with
proprietary plant-growing technology. VIVO has a collection of premium brands
targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM),
Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a
premium cannabis company based in Hope, British Columbia. Canna Farms was
B.C.’s first Licensed Producer and has several years of craft cultivation
experience and expertise, as well as a significant patient base and positive
cash flow. The company is significantly expanding its production capacity and
pursuing partnership and product development opportunities domestically, as
well as in select international markets, including Germany and Australia. VIVO
also operates Harvest Medicine, a patient-centric and highly scalable network
of specialty medical cannabis clinics as well as a free telemedicine service.
VIVO has a healthy balance sheet and is well-positioned to accelerate its
growth in Canada and internationally. For more information, visit the company’s
website at www.VivoCannabis.com.
NOTE TO INVESTORS: The latest news and updates
relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment